For their OTC business, the most innovative pharma companies are following consumer products companies: capturing vast amounts of demand-related information which is then fed into sophisticated ...

According to Reuters, one thing Takeda will not be doing is selling its over-the-counter (OTC) business as a quick ... reported that Weber believes that pharma mega-mergers have come back into ...

Lupin transfers OTC business to subsidiary for Rs ₹550-650 crore, reports strong Q3 financial performance with profit and ...

Glenmark Pharma introduces generic Xalatan ophthalmic solution, 0.005% in US: Our Bureau, Mumbai Friday, February 14, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., USA (Gle ...

Much like Sunday night’s Super Bowl, the rankings for TV ad impressions among over-the-counter (OTC) and Rx brands represented a big ... As expected, NFL coverage delivered the most reach for the ...

The business of over-the-counter pharmaceuticals is complex due to the various FDA approvals required. The FDA’s approval process for OTC pharmaceuticals involves multiple stages and types of ...

Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution.

MedPlus continued to benefit from strong sales of products under its private label brands in both the pharmaceuticals ... business. While MedPlus does not break up its revenue from OTC medicines ...

In a report released yesterday, Miyabi Yamakita from Jefferies maintained a Hold rating on Medipal Holdings (MEPDF – Research Report), with a ...

PBSV READ THE FULL PBSV RESEARCH REPORT Pharma-Bio Serv (OTC:PBSV) announced results for the year ended October 31, 2024. The headline revenue and earnings releases were below expectations quarter, ...